Abpro Holdings (ABPO) Retained Earnings (2021 - 2026)
Abpro Holdings' (ABPO) quarterly Retained Earnings came in at $117.2 million in Q1 2026, up 197.69% YoY from $39.4 million in Q1 2025, and up 6.41% on a QoQ basis from $110.2 million in Q4 2025.
Abpro Holdings (ABPO) Retained Earnings (2021 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 6 years of Retained Earnings data on file, last reported at $117.2 million in Q1 2026.
- Quarterly Retained Earnings rose 197.69% year-over-year to $117.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117.2 million (up 197.69% YoY) and the FY2025 annual result came in at $110.2 million, up 194.88% from the prior year.
- Retained Earnings climbed to $117.2 million in Q1 2026, from $110.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $117.2 million in Q1 2026 to a low of -$123.0 million in Q2 2025.
- A 5-year average of -$27.6 million and a median of -$14.8 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 5419029.95% — and 2026, when it jumped 197.69%.
- Tracing ABPO's Retained Earnings over 5 years: stood at -$97.2 million in 2022, then decreased by 12.05% to -$108.9 million in 2023, then fell by 6.64% to -$116.1 million in 2024, then jumped by 194.88% to $110.2 million in 2025, then rose by 6.41% to $117.2 million in 2026.
- The last three Retained Earnings figures came in at $117.2 million (Q1 2026), $110.2 million (Q4 2025), and $108.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -120.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.22 Mn |
| Dec 31, 2025 | 110.16 Mn |
| Sep 30, 2025 | 108.49 Mn |
| Jun 30, 2025 | -122.97 Mn |
| Mar 31, 2025 | -119.99 Mn |
| Dec 31, 2024 | -116.10 Mn |
| Sep 30, 2024 | -112.77 Mn |
| Dec 31, 2023 | -108.87 Mn |
| Sep 30, 2023 | -15.06 Mn |
| Jun 30, 2023 | -14.81 Mn |
| Mar 31, 2023 | -11.66 Mn |
| Dec 31, 2022 | -97.17 Mn |
| Sep 30, 2022 | -10.64 Mn |
| Jun 30, 2022 | -10.19 Mn |
| Mar 31, 2022 | -9.99 Mn |
| Dec 31, 2021 | -1,793.00 |